Quarterly report pursuant to Section 13 or 15(d)

Reverse Recapitalization (Tables)

v3.21.2
Reverse Recapitalization (Tables)
 6 Months Ended
Jun. 30, 2021
Business Combinations [Abstract]  
Summary of Number of Shares Of Common Stock Issued in Consummation of Merger

The number of shares of common stock issued immediately following the consummation of the Merger was:

 

RSVAC Common Stock shares outstanding prior to the Merger

 

 

28,750,000

 

Less redemption of RSVAC Common Stock shares

 

 

(15

)

RSVAC Common Stock shares

 

 

28,749,985

 

PIPE Shares issued

 

 

12,500,000

 

Merger and PIPE Shares

 

 

41,249,985

 

Legacy Enovix Common Shares (1)

 

 

103,995,643

 

Total shares of common stock immediately after the Merger

 

                        145,245,628

 

 

 (1)

The number of Legacy Enovix Common Shares was determined from the 563,316,738 shares of Legacy Enovix Common Stock outstanding immediately prior to the closing of the Merger converted at the exchange ratio of 0.1846. All fractional shares were rounded.